SCHEMBL6470929

SCHEMBL6470929

COn1c2ccccc2c2c(Br)cccc21

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
CNR2 P34972 4/20 0.34
GPR3 P46089 1/20 0.33
KRAS P01116 1/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 2/20 0.33
CNR1 P21554 2/20 0.32
ALDH1A1 P00352 4/20 0.32
MEN1 O00255 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
BACE1 P56817 1/20 0.30
MAPK1 P28482 1/20 0.30
GRM2 Q14416 1/20 0.30
JAK2 O60674 1/20 0.30
BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6472021 0.81 LMNA (0.40) SMN1; SMN2CNR2KRASKDM4ECNR1
SCHEMBL1408375 0.78 SMN1; SMN2 (0.56) SMN1; SMN2GPR3KDM4EMAPTALDH1A1
SCHEMBL18566674 0.76 GPR3 (0.58) GPR3KDM4EMAPTALDH1A1MEN1
SCHEMBL3049158 0.69 L3MBTL1 (0.61) KDM4EMAPTALDH1A1MEN1HPGD
SCHEMBL31384383 0.69 L3MBTL1 (0.61) KDM4EMAPTALDH1A1MEN1HPGD
SCHEMBL29446458 0.69 L3MBTL1 (0.61) KDM4EMAPTALDH1A1MEN1HPGD
SCHEMBL15073552 0.69 KDM4E (0.50) SMN1; SMN2KDM4EMAPTALDH1A1MEN1
SCHEMBL10277286 0.69 POLB (0.65) CNR2KRASKDM4EMAPTCNR1
SCHEMBL19163665 0.68 PDE7A (0.42) SMN1; SMN2CNR2KDM4EMAPTALDH1A1
SCHEMBL22721384 0.68 L3MBTL1 (0.44) SMN1; SMN2CNR2KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554262-A1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Glenmark Pharmaceuticals Limited (IN) 2005-07-20 EP disclosed
WO-2004037805-A1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LTD. (US) 2004-05-06 WO disclosed